Goal
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: the POST trial / Luca Livraghi, Francesca Martella, Matteo Ghilli, Catia Angiolini, Simonetta Magnanini, Erica Moretti, Carmelo Bengala, Emanuela Risi, Elena Molinara, Ilaria Pazzagli, Luca Malorni, Sara Donati, Stefano Gabellini, Angelo Martignetti, Piergiorgio Giannessi, Giuseppina Sanna, Leonardo Barellini, Chiara Biagioni, Luca Boni, Simonetta Bianchi, Manuela Roncella, Laura Biganzoli. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - ELETTRONICO. - 213:(2024), pp. 0-0.
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: the POST trial
Simonetta Bianchi;
2024
Abstract
Goal
| File | Dimensione | Formato | |
|---|---|---|---|
|
2024 Livraghi et al EJC.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.72 MB
Formato
Adobe PDF
|
1.72 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
